Duration of antiplatelet therapy after DES implantation: can we trust non-inferiority open-label trials?

Steg, Philippe Gabriel

Duration of antiplatelet therapy after DES implantation: can we trust non-inferiority open-label trials? [electronic resource] - European heart journal 04 2017 - 1044-1047 p. digital

Publication Type: Journal Article; Comment

1522-9645

10.1093/eurheartj/ehx110 doi


Drug Therapy, Combination
Drug-Eluting Stents
Humans
Platelet Aggregation Inhibitors
Ticlopidine